COVID-19：Fujifilm和Avigan与一家制药公司建立了合作关系：与Reddy博士和全球响应援助组织合作
COVID-19：
FUJIFILM：
7月1日，我们与印度的一家制药公司就COVID-19治疗药物/ Avigan建立了合作关系。
它宣布已与印度领先的制药公司Lady’s Laboratories签署协议，以独家授予海外开发和销售权。
本合同：
在中国和俄罗斯以外的地区，医生和女士等将向富士胶片方支付与销售相对应的价格，而不是拥有专有权。
为了将新的电晕作为治疗药物普及，我们将通过利用承包商的销售渠道尽早建立供应网络。
联合沟通
https://this.kiji.is/650959550778623073
Fujifilm partners with Dr. Reddy’s and Global Response Aid for deployment of a COVID-19 treatment drug outside of Japan
TOKYO, July 1, 2020
FUJIFILM Corporation partners with
Dr. Reddy’s Laboratories Ltd. , a global pharmaceutical company headquartered in India
and
Global Response Aid , a global provider of medical supplies and pharmaceuticals,
aimed at overseas deployment of a treatment drug for the novel coronavirus infectious disease, or COVID-19.
On June 30, a Tripartite Licensing Agreement was concluded between
- FUJIFILM Toyama Chemical Co., Ltd.,
- Dr. Reddy’s, and
- GRA,
concerning the development, manufacture and sales of Avigan® Tablets (generic name: favipiravir) (hereinafter “Avigan”), which is a potential drug for a treatment of COVID-19.
Under the Agreement, FUJIFILM Toyama Chemical
will grant Dr. Reddy’s and GRA the exclusive right to develop, manufacture*1 and sell Avigan overseas*2, and, receive a lump-sum license fee and royalties on sales.
Based on the Agreement, FUJIFILM Toyama Chemical
will provide Dr. Reddy’s and GRA an array of data on Avigan’s preclinical and clinical studies that
FUJIFILM Toyama Chemical
has accumulated thus far. Dr. Reddy’s and GRA, for their part, will make use of this data to swiftly implement clinical studies,
targeting COVID-19 patients in
- India,
- the Middle East, and
- other regions where infections have been spreading.
In addition, FUJIFILM Toyama Chemical
will grant Dr. Reddy’s right to use Avigan’s patents of formulation and manufacturing method.
Dr. Reddy’s
will herewith establish a setup for manufacturing drugs of the same quality as Avigan, and utilize GRA’s global sales network to supply the manufactured drugs swiftly and in a stable manner.
Dr. Reddy’s is a global pharmaceutical company which develops, manufactures, and sells generic drugs.
It has been expanding business not only in India but also in Europe, the US and several other markets across the world and is accelerating its global business development.
GRA, a company based in Dubai,
offers medical supplies, drugs, and medical services worldwide in cooperation with drug and medical device manufacturers.
Fujifilm [Japan]
https://www.fujifilm.com/jp/en/news/hq/5109
Dr. Reddy’s partners with FUJIFILM and Global Response Aid for Avigan® (favipiravir), a potential treatment of COVID-19
https://www.drreddys.com/media/904732/press-release_dr-reddys-avigan.pdf
Agility launches Dubai-based Global Response Aid in Covid-19 fight